top of page

BHP logo_withtext_square_edited.png

Newspapers

BHP Insights

Image illustrating GLP-1 therapies moving beyond metabolic disease toward potential treatments for Alzheimer’s, Parkinson’s, anxiety, depression, and other neurological disorders.

Image illustrating GLP-1 therapies moving beyond metabolic disease toward potential treatments for Alzheimer’s, Parkinson’s, anxiety, depression, and other neurological disorders.

Expanding GLP-1s: is Neurology the Next Frontier?

GLP-1 therapies transformed obesity & diabetes care and are now being explored for potential breakthroughs in neurological diseases.

Apr 2, 2025

Interested in learning more?

Get in Touch

Are you a health tech founder?

Submit Investor Materials

bottom of page